Extracellular vesicles secreted from mesenchymal stem cells ameliorate renal ischemia reperfusion injury by delivering miR-100-5p targeting FKBP5/AKT axis

• Published in: Scientific reports 2024-03, Vol.14 (1), p.6720-6720, Article 6720
• Main Authors: Chen, Guo, Li, Xinyuan, Zhou, Xiang, Li, Yang, Yu, Haitao, Peng, Xiang, Bai, Xuesong, Zhang, Chunlin, Feng, Zhenwei, Mei, Yuhua, Li, Li, Liu, Yu, Gou, Xin, Jiang, Yuanbin
• Format: Article
• Language: English
• Subjects: 631/154; 631/443; 631/45; 631/532; 631/80; 692/308; 692/4017; 692/4022; 692/4025; 692/420; Acute Kidney Injury - pathology; AKT protein; Animals; Apoptosis; Exosomes - metabolism; Extracellular vesicles; Extracellular Vesicles - metabolism; FKBP5; Human umbilical cord mesenchymal stem cells; Humanities and Social Sciences; Humans; Ischemia; Ischemia–reperfusion injury; Kidney diseases; Kidneys; Mesenchymal stem cells; Mesenchymal Stem Cells - metabolism; Mice; MicroRNAs - genetics; MicroRNAs - metabolism; miR-100-5p; multidisciplinary; Phosphorylation; Proto-Oncogene Proteins c-akt - metabolism; Reperfusion; Reperfusion Injury - genetics; Reperfusion Injury - metabolism; Reperfusion Injury - therapy; Science; Science (multidisciplinary); Small extracellular vesicles; Stem cells; Umbilical cord
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-024-56950-1

The incidence of acute kidney injury (AKI) due to ischemia–reperfusion (IR) injury is increasing. There is no effective treatment for AKI, and because of this clinical challenge, AKI often progresses to chronic kidney disease, which is closely associated with poor patient outcomes and high mortality rates. Small extracellular vesicles from human umbilical cord mesenchymal stem cells (hUCMSC-sEVs) play increasingly vital roles in protecting tissue function from the effects of various harmful stimuli owing to their specific biological features. In this study, we found that miR-100-5p was enriched in hUCMSC-sEVs, and miR-100-5p targeted FKBP5 and inhibited HK-2 cell apoptosis by activating the AKT pathway. HK-2 cells that were exposed to IR injury were cocultured with hUCMSC-sEVs, leading to an increase in miR-100-5p levels, a decrease in FKBP5 levels, and an increase in AKT phosphorylation at Ser 473 (AKT-473 phosphorylation). Notably, these effects were significantly reversed by transfecting hUCMSCs with an miR-100-5p inhibitor. Moreover, miR-100-5p targeted FKBP5, as confirmed by a dual luciferase reporter assay. In vivo, intravenous infusion of hUCMSC-sEVs into mice suffering from IR injury resulted in significant apoptosis inhibition, functional maintenance and renal histological protection, which in turn decreased FKBP5 expression levels. Overall, this study revealed an effect of hUCMSC-sEVs on inhibiting apoptosis; hUCMSC-sEVs reduced renal IR injury by delivering miR-100-5p to HK-2 cells, targeting FKBP5 and thereby promoting AKT-473 phosphorylation to activate the AKT pathway. This study provides novel insights into the role of hUCMSC-sEVs in the treatment of AKI.